Mizue Terai

1.9k citations
41 papers · 1.3k indexed · h-index 19
Topics
Ocular Oncology and Treatments (28 papers)Immunotherapy and Immune Responses (15 papers)Ubiquitin and proteasome pathways (5 papers)
Journals
Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Mizue Terai

41 papers receiving 1.2k citations

Peers

Mizue Terai
Comparison fields: 5 of 73
  • Ophthalmology 480
  • Immunology 476
  • Oncology 453
  • Molecular Biology 424
  • Epidemiology 221
Replace Frank M. Speetjens with:
Frank M. Speetjens Netherlands
Smita S. Chandran United States
Natalia Aptsiauri Spain
Katie A. Matatall United States
Kalijn F. Bol Netherlands
Antonio Rullan United Kingdom
Catherine Sibille Belgium
Gregorius P. M. Luyten Netherlands
Yafei Hou United States
Martin Guimond United States
Mizue Terai relative to Frank M. Speetjens Netherlands Frank M. Speetjens's profile →
Citations per field
00.5×3.1×
Frank M. Speetjens · 1×
Citations per year

Countries citing papers authored by Mizue Terai

Since Specialization
Citations

This map shows the geographic impact of Mizue Terai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mizue Terai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mizue Terai more than expected).

Fields of papers citing papers by Mizue Terai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mizue Terai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mizue Terai. The network helps show where Mizue Terai may publish in the future.

Co-authorship network of co-authors of Mizue Terai

This figure shows the co-authorship network connecting the top 25 collaborators of Mizue Terai. A scholar is included among the top collaborators of Mizue Terai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mizue Terai. Mizue Terai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 5
4 3
5 10
6 7
7 37
8 69
9 54
10 35
11 53
12 23
13 59
14 33
15 18
16 30
17 200
18 18
19 9
20 174

About Mizue Terai

Mizue Terai is a scholar working on Ophthalmology, Immunology and Oncology, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (28 papers), Immunotherapy and Immune Responses (15 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Ophthalmology (480 citations), Immunology (476 citations) and Oncology (453 citations). Mizue Terai has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Takami Sato, Michael J. Mastrangelo, Yutaka Tamura, Vitali Alexeev, Andrew E. Aplin, Senthamil R. Selvan, Inna Chervoneva, Ken Kageyama, David Berd and David J. Eschelman. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026